Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 8

Showing 8 citing articles:

Novel 3‐Substituted‐2H‐Chromene Scaffold Based Fluorinated Hydrophobic Fragment as In‐Vitro Antiproliferative Agents and Apoptosis Inducers Targeting Both VEGFR‐2/BRAFV600E and h‐DHFR With Molecular Docking Simulation
Mohamed A. Salem, Moustafa S. Abusaif, Nirvana A. Gohar, et al.
Drug Development Research (2025) Vol. 86, Iss. 2
Closed Access | Times Cited: 2
New pyrrolo[3,4-d] isoxazolidines hbrid with furan as multi-target antitumor agents and multi-target enzyme inhibitors: Synthesis and in silico study
Awаd I. Said, Wafaa A Ewes, Abdelrahman Hamdi, et al.
Bioorganic Chemistry (2025), pp. 108377-108377
Closed Access
Design and synthesis of novel 2-S-alkylated Quinazolinones as dual BRAFV600E and EGFR inhibitors in melanoma: Mechanistic insights from apoptosis and cell cycle modulation
Hamed W. El-Shafey, Mohammad M. Al‐Sanea, Mohamed R. Elnagar, et al.
Bioorganic Chemistry (2025), pp. 108526-108526
Closed Access
Design, Synthesis and Molecular Docking of New Thieno[2,3‑d]Pyrimidin‐4‐One Derivatives as Dual EGFR and FGFR Inhibitors
Sara Sultan, Samar S. Tawfik, Khalid B. Selim, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4(3H)-quinazolinones with promising EGFR/VEGFR-2 inhibitory activities
Abdelrahman Hamdi, Samar S. Tawfik, Ahmed R. Ali, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107951-107951
Closed Access | Times Cited: 2
Halogen‐based quinazolin‐4(3H)‐one derivatives as MCF‐7 breast cancer inhibitors: Current developments and structure–activity relationship
Rachana Upadhyay, P. K. Tandel, Amit B. Patel
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access | Times Cited: 1
Molecular Docking: An Emerging Tool for Target-Based Cancer Therapy
Pavithra Uppathi, Suraj Rajakumari, K. V. Saritha
Critical Reviews™ in Oncogenesis (2024) Vol. 30, Iss. 1, pp. 1-13
Closed Access
Design, synthesis, and in vitro and in vivo biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agents
Heba Adawy, Samar S. Tawfik, Abdullah A. Elgazar, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35239-35254
Open Access
Page 1

Scroll to top